[HTML][HTML] Characterizing influence of rCHOP treatment on diffuse large B-cell lymphoma microenvironment through in vitro microfluidic spheroid model

MR Sullivan, RP White, D Ravi, N Kanetkar… - Cell Death & …, 2024 - nature.com
For over two decades, Rituximab and CHOP combination treatment (rCHOP) has remained
the standard treatment approach for diffuse large B-cell lymphoma (DLBCL). Despite …

Characterizing influence of rCHOP treatment on diffuse large B-cell lymphoma microenvironment through in vitro microfluidic spheroid model

MR Sullivan, RP White, D Ravi, N Kanetkar… - Cell Death & …, 2024 - par.nsf.gov
For over two decades, Rituximab and CHOP combination treatment (rCHOP) has remained
the standard treatment approach for diffuse large B-cell lymphoma (DLBCL). Despite …

[HTML][HTML] Characterizing influence of rCHOP treatment on diffuse large B-cell lymphoma microenvironment through in vitro microfluidic spheroid model

MR Sullivan, RP White, D Ravi, N Kanetkar… - Cell Death & …, 2024 - ncbi.nlm.nih.gov
For over two decades, Rituximab and CHOP combination treatment (rCHOP) has remained
the standard treatment approach for diffuse large B-cell lymphoma (DLBCL). Despite …

Characterizing influence of rCHOP treatment on diffuse large B-cell lymphoma microenvironment through in vitro microfluidic spheroid model

MR Sullivan, RP White, D Ravi… - Cell death & …, 2024 - pubmed.ncbi.nlm.nih.gov
For over two decades, Rituximab and CHOP combination treatment (rCHOP) has remained
the standard treatment approach for diffuse large B-cell lymphoma (DLBCL). Despite …

Characterizing influence of rCHOP treatment on diffuse large B-cell lymphoma microenvironment through in vitro microfluidic spheroid model

MR Sullivan, RP White, D Ravi… - Cell Death and …, 2024 - search.proquest.com
For over two decades, Rituximab and CHOP combination treatment (rCHOP) has remained
the standard treatment approach for diffuse large B-cell lymphoma (DLBCL). Despite …

Characterizing influence of rCHOP treatment on diffuse large B-cell lymphoma microenvironment through in vitro microfluidic spheroid model

MR Sullivan, RP White, RD Ravi… - Cell Death and …, 2024 - researchwithrutgers.com
For over two decades, Rituximab and CHOP combination treatment (rCHOP) has remained
the standard treatment approach for diffuse large B-cell lymphoma (DLBCL). Despite …

Characterizing influence of rCHOP treatment on diffuse large B-cell lymphoma microenvironment through in vitro microfluidic spheroid model.

MR Sullivan, RP White, D Ravi, N Kanetkar… - Cell Death & …, 2024 - europepmc.org
For over two decades, Rituximab and CHOP combination treatment (rCHOP) has remained
the standard treatment approach for diffuse large B-cell lymphoma (DLBCL). Despite …

Characterizing influence of rCHOP treatment on diffuse large B-cell lymphoma microenvironment through in vitro microfluidic spheroid model.

MR Sullivan, RP White, D Ravi… - Cell Death & …, 2024 - search.ebscohost.com
For over two decades, Rituximab and CHOP combination treatment (rCHOP) has remained
the standard treatment approach for diffuse large B-cell lymphoma (DLBCL). Despite …

[引用][C] Characterizing influence of rCHOP treatment on diffuse large B-cell lymphoma microenvironment through in vitro microfluidic spheroid model

MR Sullivan, RP White, D Ravi, N Kanetkar… - Cell Death and …, 2024 - europepmc.org
Diffuse large B-cell lymphoma (DLBCL) is the most common form of non-HodgkinLs
lymphoma [1]. The standard method of treatment is a chemotherapy cocktail comprised of …